Cleared Traditional

K991904 - MODIFICATION OF JMS NEEDLES AND JMS SYR...

K991904 is the FDA 510(k) clearance for MODIFICATION OF JMS NEEDLES AND JMS SYR... by Jms Co., Ltd.. It is a Class 2 General Hospital device (product code FMI) cleared through the Traditional 510(k) pathway after a 88-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1999
Decision
88d
Days
Class 2
Risk

K991904 is an FDA 510(k) clearance for the MODIFICATION OF JMS NEEDLES AND JMS SYRINGES. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Jms Co., Ltd. (Hiroshima, 730, JP). The FDA issued a Cleared decision on August 31, 1999 after a review of 88 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Jms Co., Ltd. devices

Submission Details

510(k) Number K991904 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 1999
Decision Date August 31, 1999
Days to Decision 88 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 129d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 237
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K991904.
BODYGUARD
K000441 · Vital Signs, Inc. · Apr 2000
LUER ACCESS UNIVERSAL VIAL ADAPTER
K000657 · Baxter Healthcare Corp · Mar 2000
TERUMO NEEDLE WITH LOCKING SHEATH
K000387 · Terumo Medical Corp. · Mar 2000
DEROYAL INDUSTRIES, INC TRACECART SHARPS COLLECTION CONTAINER
K983750 · Deroyal Industries, Inc. · Nov 1998
BLUNT SYRINGE CANNULA
K971924 · B.Braun Medical, Inc. · Sep 1998
BECTON DICKINSON BLUNT PLASTIC CANNULA
K974363 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jun 1998